8 results on '"Paredes-Moreno, Beatriz"'
Number of results to display per page
Search Results
2. Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children
- Author
-
Mesa-Herrera, María Elena, García-Cristiá, Yarmila, Verdecia-Sánchez, Leonor, del Valle Rodríguez, Rafael, Oquendo-de la Cruz, Yudalvies, Álvarez-Montalvo, Daysi, Grillo-Fortún, Randy, López-González, Liset, Galindo, Omaida Fonte, Reyes-González, Yeseni, González-Álvarez, Ana Beatriz, Gorrita-Mora, Linet, Valera-Fernández, Rodrigo, Ontivero-Pino, Ivis, Martínez-Pérez, Marisel, Caballero-Gonzalez, Esperanza, Garcés-Hechavarría, Aniurka, Martínez-Bedoya, Dayle, Medina-Nápoles, Maite, Domínguez-Pentón, Yeney Regla, Cazañas-Quintana, Yadira, Barrios, Thais Fundora, Fernández, Diana R. Hernández, Bergado-Báez, Gretchen, Orosa-Vazquez, Ivette, Pi-Estopiñan, Franciscary, Díaz-Hernández, Marianniz, Cruz-Sui, Otto, Noa-Romero, Enrique, García-López, Arilia, Muro, Sandra Rivadereira, Baro-Roman, Gerardo, Puga-Gómez, Rinaldo, Ricardo-Delgado, Yariset, Rojas-Iriarte, Chaumey, Céspedes-Henriquez, Leyanis, Piedra-Bello, Misleidys, Vega-Mendoza, Dania, Pérez, Noelvia Pestana, Paredes-Moreno, Beatriz, Rodríguez-González, Meiby, Valenzuela-Silva, Carmen, Sánchez-Ramírez, Belinda, Rodríguez-Noda, Laura, Pérez-Nicado, Rocmira, González-Mugica, Raul, Hernández-García, Tays, Fundora-Barrios, Talía, Echevarría, Martha Dubet, Enriquez-Puertas, Juliet María, Infante-Hernández, Yenicet, Palenzuela-Díaz, Ariel, Gato-Orozco, Evelyn, Chappi-Estévez, Yanet, Francisco-Pérez, Julio Cesar, Suarez-Martinez, Miladi, Castillo-Quintana, Ismavy C., Fernandez-Castillo, Sonsire, Climent-Ruiz, Yanet, Santana-Mederos, Darielys, García-Vega, Yanelda, Toledo-Romani, María Eugenia, Doroud, Delaram, Biglari, Alireza, Valdés-Balbín, Yury, García-Rivera, Dagmar, and Vérez-Bencomo, Vicente
- Published
- 2023
- Full Text
- View/download PDF
3. Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults
- Author
-
Cubas-Curbelo, Mailin, Rodríguez-Castillo, Pedro Gabriel, Acevedo-Martínez, Yosmel, Estoque-Cabrera, Solangel, Ávila-Cabreja, José Alejandro, Alfaro-Guzmán, Ainadis, Zulueta-Pérez, Lilian, Espino-Rojas, Niurka Tamara, Medinas-Santos, Gloria Margarita, Sarda-Rodriguez, Ileana Luisa, Acosta-Martinez, Mario Alejandro, Reyes-Matienzo, Radamet, Coviella-Artime, José Manuel, Morffi-Cinta, Irania, Martínez-Pérez, Marisel, Valera-Fernández, Rodrigo, Garcés-Hechavarría, Aniurka, Martínez-Bedoya, Dayle, Garrido-Arteaga, Raine, Cardoso-SanJorge, Félix, Ramírez-Gonzalez, Ubel, Quintero-Moreno, Lauren, Ontivero-Pino, Ivis, Martínez-Rivera, Roselyn, Guillén-Obregón, Berta, Lora-García, Janet, Medina-Nápoles, Maite, Espi-Ávila, Jennifer, Fontanies-Fernández, Marcos, Domínguez-Pentón, Yeney Regla, Bergado-Baez, Gretchen, Pi-Estopiñán, Franciscary, Ojito-Magaz, Eduardo, Rodríguez, Misladys, Cruz-Sui, Otto, García-Montero, Majela, Dubed-Echevarría, Marta, García-López, Elena, Galano-Frutos, Evelyn, Perez-Perez, Alina, Morales-Ruano, Susana, Brito-Pascual, Idalmis, Amoroto, Maité, Arteaga-García, Amaylid, Toledo-Romani, María Eugenia, García-Carmenate, Mayra, Verdecia-Sánchez, Leslyhana, Pérez-Rodríguez, Suzel, Rodriguez-González, Meybis, Valenzuela-Silva, Carmen, Paredes-Moreno, Beatriz, Sanchez-Ramirez, Belinda, González-Mugica, Raúl, Hernández-Garcia, Tays, Orosa-Vázquez, Ivette, Díaz-Hernández, Marianniz, Pérez-Guevara, María Teresa, Enriquez-Puertas, Juliet, Noa-Romero, Enrique, Palenzuela-Diaz, Ariel, Baro-Roman, Gerardo, Mendoza-Hernández, Ivis, Muñoz, Yaima, Gómez-Maceo, Yanet, Santos-Vega, Bertha Leysi, Fernandez-Castillo, Sonsire, Climent-Ruiz, Yanet, Rodríguez-Noda, Laura, Santana-Mederos, Darielys, García-Vega, Yanelda, Chen, Guang-Wu, Doroud, Delaram, Biglari, Alireza, Boggiano-Ayo, Tammy, Valdés-Balbín, Yury, Rivera, Daniel G., García-Rivera, Dagmar, and Vérez-Bencomo, Vicente
- Published
- 2022
- Full Text
- View/download PDF
4. Comparative Immune Response after Vaccination with SOBERANA® 02 and SOBERANA® plus Heterologous Scheme and Natural Infection in Young Children
- Author
-
Pérez-Nicado, Rocmira, primary, Massa, Chiara, additional, Rodríguez-Noda, Laura Marta, additional, Müller, Anja, additional, Puga-Gómez, Rinaldo, additional, Ricardo-Delgado, Yariset, additional, Paredes-Moreno, Beatriz, additional, Rodríguez-González, Meiby, additional, García-Ferrer, Marylé, additional, Palmero-Álvarez, Ilianet, additional, Garcés-Hechavarría, Aniurka, additional, Rivera, Daniel G., additional, Valdés-Balbín, Yury, additional, Vérez-Bencomo, Vicente, additional, García-Rivera, Dagmar, additional, and Seliger, Barbara, additional
- Published
- 2023
- Full Text
- View/download PDF
5. Comparative Immune Response after Vaccination with SOBERANA ® 02 and SOBERANA ® plus Heterologous Scheme and Natural Infection in Young Children.
- Author
-
Pérez-Nicado, Rocmira, Massa, Chiara, Rodríguez-Noda, Laura Marta, Müller, Anja, Puga-Gómez, Rinaldo, Ricardo-Delgado, Yariset, Paredes-Moreno, Beatriz, Rodríguez-González, Meiby, García-Ferrer, Marylé, Palmero-Álvarez, Ilianet, Garcés-Hechavarría, Aniurka, Rivera, Daniel G., Valdés-Balbín, Yury, Vérez-Bencomo, Vicente, García-Rivera, Dagmar, and Seliger, Barbara
- Subjects
MULTISYSTEM inflammatory syndrome ,IMMUNE response ,VACCINE effectiveness ,IMMUNOLOGIC memory ,VACCINATION of children ,GRANZYMES ,BACTERIAL vaccines - Abstract
(1) Background: In children, SARS-CoV-2 infection is mostly accompanied by mild COVID-19 symptoms. However, multisystem inflammatory syndrome (MIS-C) and long-term sequelae are often severe complications. Therefore, the protection of the pediatric population against SARS-CoV-2 with effective vaccines is particularly important. Here, we compare the humoral and cellular immune responses elicited in children (n = 15, aged 5–11 years) vaccinated with the RBD-based vaccines SOBERANA
® 02 and SOBERANA® Plus combined in a heterologous scheme with those from children (n = 10, aged 4–11 years) who recovered from mild symptomatic COVID-19. (2) Methods: Blood samples were taken 14 days after the last dose for vaccinated children and 45–60 days after the infection diagnosis for COVID-19 recovered children. Anti-RBD IgG and ACE2-RBD inhibition were assessed by ELISA; IgA, cytokines, and cytotoxic-related proteins were determined by multiplex assays. Total B and T cell subpopulations and IFN-γ release were measured by multiparametric flow cytometry using a large panel of antibodies after in vitro stimulation with S1 peptides. (3) Results: Significant higher levels of specific anti-RBD IgG and IgA and ACE2-RBD inhibition capacity were found in vaccinated children in comparison to COVID-19 recovered children. Th1-like and Th2-like CD4+ T cells were also significantly higher in vaccinated subjects. IFN-γ secretion was higher in central memory CD4+ T cells of COVID-19 recovered children, but no differences between both groups were found in the CD4+ and CD8+ T cell effector, terminal effector, and naïve T cell subpopulations. In contrast to low levels of IL-4, high levels of IL-2, IL-6, IFN-γ, and IL-10 suggest a predominant Th1 cell polarization. Cytotoxic-related proteins granzyme A and B, perforin, and granulin were also found in the supernatant after S1 stimulation in both vaccinated and recovered children. (4) Conclusions: Vaccination with the heterologous scheme of SOBERANA® 02/SOBERANA® Plus induces a stronger antibody and cellular immune response compared to natural infections in young children. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
6. Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children
- Author
-
Puga-Gómez, Rinaldo, primary, Ricardo-Delgado, Yariset, additional, Rojas-Iriarte, Chaumey, additional, Céspedes-Henriquez, Leyanis, additional, Piedra-Bello, Misleidys, additional, Vega-Mendoza, Dania, additional, Pérez, Noelvia Pestana, additional, Paredes-Moreno, Beatriz, additional, Rodríguez-González, Meiby, additional, Valenzuela-Silva, Carmen, additional, Sánchez-Ramírez, Belinda, additional, Rodríguez-Noda, Laura, additional, Pérez-Nicado, Rocmira, additional, González-Mugica, Raul, additional, Hernández-García, Tays, additional, Fundora-Barrios, Talía, additional, Echevarría, Martha Dubet, additional, Enriquez-Puertas, Juliet María, additional, Infante-Hernández, Yenicet, additional, Palenzuela-Díaz, Ariel, additional, Gato-Orozco, Evelyn, additional, Chappi-Estévez, Yanet, additional, Francisco-Pérez, Julio Cesar, additional, Suarez-Martinez, Miladi, additional, Castillo-Quintana, Ismavy C., additional, Fernandez-Castillo, Sonsire, additional, Climent-Ruiz, Yanet, additional, Santana-Mederos, Darielys, additional, García-Vega, Yanelda, additional, Toledo-Romani, María Eugenia, additional, Doroud, Delaram, additional, Biglari, Alireza, additional, Valdés-Balbín, Yury, additional, García-Rivera, Dagmar, additional, Vérez-Bencomo, Vicente, additional, Mesa-Herrera, María Elena, additional, García-Cristiá, Yarmila, additional, Verdecia-Sánchez, Leonor, additional, del Valle Rodríguez, Rafael, additional, Oquendo-de la Cruz, Yudalvies, additional, Álvarez-Montalvo, Daysi, additional, Grillo-Fortún, Randy, additional, López-González, Liset, additional, Galindo, Omaida Fonte, additional, Reyes-González, Yeseni, additional, González-Álvarez, Ana Beatriz, additional, Gorrita-Mora, Linet, additional, Valera-Fernández, Rodrigo, additional, Ontivero-Pino, Ivis, additional, Martínez-Pérez, Marisel, additional, Caballero-Gonzalez, Esperanza, additional, Garcés-Hechavarría, Aniurka, additional, Martínez-Bedoya, Dayle, additional, Medina-Nápoles, Maite, additional, Domínguez-Pentón, Yeney Regla, additional, Cazañas-Quintana, Yadira, additional, Barrios, Thais Fundora, additional, Fernández, Diana R. Hernández, additional, Bergado-Báez, Gretchen, additional, Orosa-Vazquez, Ivette, additional, Pi-Estopiñan, Franciscary, additional, Díaz-Hernández, Marianniz, additional, Cruz-Sui, Otto, additional, Noa-Romero, Enrique, additional, García-López, Arilia, additional, Muro, Sandra Rivadereira, additional, and Baro-Roman, Gerardo, additional
- Published
- 2023
- Full Text
- View/download PDF
7. Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults
- Author
-
Toledo-Romani, María Eugenia, primary, García-Carmenate, Mayra, additional, Verdecia-Sánchez, Leslyhana, additional, Pérez-Rodríguez, Suzel, additional, Rodriguez-González, Meybis, additional, Valenzuela-Silva, Carmen, additional, Paredes-Moreno, Beatriz, additional, Sanchez-Ramirez, Belinda, additional, González-Mugica, Raúl, additional, Hernández-Garcia, Tays, additional, Orosa-Vázquez, Ivette, additional, Díaz-Hernández, Marianniz, additional, Pérez-Guevara, María Teresa, additional, Enriquez-Puertas, Juliet, additional, Noa-Romero, Enrique, additional, Palenzuela-Diaz, Ariel, additional, Baro-Roman, Gerardo, additional, Mendoza-Hernández, Ivis, additional, Muñoz, Yaima, additional, Gómez-Maceo, Yanet, additional, Santos-Vega, Bertha Leysi, additional, Fernandez-Castillo, Sonsire, additional, Climent-Ruiz, Yanet, additional, Rodríguez-Noda, Laura, additional, Santana-Mederos, Darielys, additional, García-Vega, Yanelda, additional, Chen, Guang-Wu, additional, Doroud, Delaram, additional, Biglari, Alireza, additional, Boggiano-Ayo, Tammy, additional, Valdés-Balbín, Yury, additional, Rivera, Daniel G., additional, García-Rivera, Dagmar, additional, Vérez-Bencomo, Vicente, additional, Cubas-Curbelo, Mailin, additional, Rodríguez-Castillo, Pedro Gabriel, additional, Acevedo-Martínez, Yosmel, additional, Estoque-Cabrera, Solangel, additional, Ávila-Cabreja, José Alejandro, additional, Alfaro-Guzmán, Ainadis, additional, Zulueta-Pérez, Lilian, additional, Espino-Rojas, Niurka Tamara, additional, Medinas-Santos, Gloria Margarita, additional, Sarda-Rodriguez, Ileana Luisa, additional, Acosta-Martinez, Mario Alejandro, additional, Reyes-Matienzo, Radamet, additional, Coviella-Artime, José Manuel, additional, Morffi-Cinta, Irania, additional, Martínez-Pérez, Marisel, additional, Valera-Fernández, Rodrigo, additional, Garcés-Hechavarría, Aniurka, additional, Martínez-Bedoya, Dayle, additional, Garrido-Arteaga, Raine, additional, Cardoso-SanJorge, Félix, additional, Ramírez-Gonzalez, Ubel, additional, Quintero-Moreno, Lauren, additional, Ontivero-Pino, Ivis, additional, Martínez-Rivera, Roselyn, additional, Guillén-Obregón, Berta, additional, Lora-García, Janet, additional, Medina-Nápoles, Maite, additional, Espi-Ávila, Jennifer, additional, Fontanies-Fernández, Marcos, additional, Domínguez-Pentón, Yeney Regla, additional, Bergado-Baez, Gretchen, additional, Pi-Estopiñán, Franciscary, additional, Ojito-Magaz, Eduardo, additional, Rodríguez, Misladys, additional, Cruz-Sui, Otto, additional, García-Montero, Majela, additional, Dubed-Echevarría, Marta, additional, García-López, Elena, additional, Galano-Frutos, Evelyn, additional, Perez-Perez, Alina, additional, Morales-Ruano, Susana, additional, Brito-Pascual, Idalmis, additional, Amoroto, Maité, additional, and Arteaga-García, Amaylid, additional
- Published
- 2022
- Full Text
- View/download PDF
8. Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial
- Author
-
Toledo-Romaní, María Eugenia, García-Carmenate, Mayra, Valenzuela-Silva, Carmen, Baldoquín-Rodríguez, Waldemar, Martínez-Pérez, Marisel, Rodríguez-González, Meiby, Paredes-Moreno, Beatriz, Mendoza-Hernández, Ivis, González-Mujica Romero, Raúl, Samón-Tabio, Oscar, Velazco-Villares, Pablo, Bacallao-Castillo, Juan Pablo, Licea-Martín, Ernesto, Rodríguez-Ortega, Misladys, Herrera-Marrero, Nuris, Caballero-González, Esperanza, Egües-Torres, Liudmila, Duartes-González, Reinaldo, García-Blanco, Serguey, Pérez-Cabrera, Suzette, Huete-Ferreira, Santos, Idalmis-Cisnero, Kirenia, Fonte-Galindo, Omayda, Meliá-Pérez, Dania, Rojas-Remedios, Ivonne, Doroud, Delaram, Mehdi Gouya, Mohammad, Biglari, Alireza, Fernández-Castillo, Sonsire, Climent-Ruiz, Yanet, Valdes-Balbín, Yury, García-Rivera, Dagmar, Van der Stuyft, Patrick, and Verez-Bencomo, Vicente
- Abstract
SOBERANA-02 es una vacuna conjugada contra la COVID-19 (RBD recombinante conjugado a toxoide tetánico). Los ensayos clínicos fase 1/2 demostraron la inducción de anticuerpos IgG neutralizantes y respuesta de células T específicas. Una tercera dosis heteróloga de SOBERANA-Plus (dímero RBD) incrementó los anticuerpos neutralizantes. El objetivo de este estudio es evaluar la seguridad y eficacia de dos esquemas de inmunización: dos dosis de SOBERANA-02 y una combinación heteróloga de adicionando una tercera dosis con SOBERANA-Plus.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.